EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-COV-2 causes significant abnormalities in the fibrinolysis system of patients: correlation between viral mutations, variants and thrombosis

Esra'a Abudouleh, Tarek Owaidah, Fatimah Alhamlan, Arwa A Al-Qahtani, Reem M Aljowaie, Fatimah Al-Ghnnam, Marie Fe Bohol, Ahmed A Al-Qahtani

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1531412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Esra'a Abudouleh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Thrombosis, Fibrinolysis. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal Specialist Hospital and Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus disease (COVID-19) is reported as a complex disorder affecting multiple systems and coagulopathy that can cause mortality. In this study, we investigated the correlation of SARS-CoV-2 mutations found in blood samples with various changes in the fibrinolysis system, as well as the severity of the disease based on outcome and whether or not these patients were admitted into the ICU. Materials and methods COVID-19 patients (n = 446) admitted to our institute between 2021 and 2022 were recruited. Blood samples were collected, and a sequence analysis of the SARS-CoV-2 spike gene was isolated from the blood. Measured several parameters of fibrinolysis and coagulation, including alpha-2-antiplasmin and plasminogen, thrombin activatable fibrinolysis inhibitor (TAFI), tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), D-dimer, and fibrinogen levels.

Results

SARS-CoV-2 RNA was found in 123/446 (27.6%) of the blood samples. The N501Y, D614G, K417N, and P681R mutations among COVID-19 patients were associated with higher admissions to the ICU (P = 0.0057, P = 0.0068, P = 0.0193, and P = 0.018, respectively). Omicron (BA.1.1) variant variants are highly associated with thrombosis (P = 0.002) in hospitalized COVID-19 patients that are unvaccinated and have comorbidity conditions. The plasma levels of tPA, aPTT, and D-dimer were significantly higher in participants who had the N501Y mutation (P = 0.044, P = 0.024, and P = 0.027, respectively).

Conclusion

Thrombosis was the most prevalent condition among severe COVID-19 patients. The correlation between specific SARS-CoV-2 new variants and thrombosis warrants more investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2ThrombosisFibrinolysisHumansMaleFemaleMiddle AgedMutationAgedAdultSpike Glycoprotein, CoronavirusRNA, ViralAged, 80 and overFibrinogenSeverity of Illness IndexTissue Plasminogen ActivatorCarboxypeptidase B2Plasminogen Activator Inhibitor 1

Stichwörter der Autor:innen

SARS-CoV-2 RNAemiaSARS-CoV2 mutationsactivatable fibrinolysis inhibitorplasminogen activator inhibitor (PAI-1)thrombinthrombosistissue plasminogen activator (tPA)

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2RNA, ViralFibrinogenTissue Plasminogen ActivatorCarboxypeptidase B2Plasminogen Activator Inhibitor 1

Autor:innen und Institutionen

  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Department of Pathology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Department of Infection and Immunity, Research Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Department of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Department of Family Medicine, College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.

Förderung

  • King Faisal Specialist Hospital and Research Centre

Zitieren

APA

Abudouleh, E., Owaidah, T., Alhamlan, F., Al-Qahtani, A. A., Aljowaie, R. M., Al-Ghnnam, F., Fe Bohol, M., & Al-Qahtani, A. A. (2025). SARS-COV-2 causes significant abnormalities in the fibrinolysis system of patients: correlation between viral mutations, variants and thrombosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1531412

Vancouver

Abudouleh E, Owaidah T, Alhamlan F, Al-Qahtani AA, Aljowaie RM, Al-Ghnnam F, et al. SARS-COV-2 causes significant abnormalities in the fibrinolysis system of patients: correlation between viral mutations, variants and thrombosis. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1531412

BibTeX
@article{Abudouleh2025,
  author = {Abudouleh, Esra'a and Owaidah, Tarek and Alhamlan, Fatimah and Al-Qahtani, Arwa A and Aljowaie, Reem M and Al-Ghnnam, Fatimah and Fe Bohol, Marie and Al-Qahtani, Ahmed A},
  title = {SARS-COV-2 causes significant abnormalities in the fibrinolysis system of patients: correlation between viral mutations, variants and thrombosis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1531412}
}
Kostenlos starten →